Literature DB >> 9631514

Secretion of biologically active human interleukin-2 and interleukin-4 from genetically modified tobacco cells in suspension culture.

N S Magnuson1, P M Linzmaier, R Reeves, G An, K HayGlass, J M Lee.   

Abstract

Biologically active human interleukin-2 (IL-2) and IL-4, key lymphokines involved in immune regulation, were produced and secreted into the medium by genetically modified Nicotiana tabacum cells grown in suspension culture. Secretion through the plasma membrane and cell wall into the medium was facilitated by the natural mammalian leader sequences. IL-2 and IL-4 were detected in the medium at concentrations of 0.10 and 0.18 microgram/mL, respectively, although higher levels were detected within the lymphokine-producing cells (approximately 0.80 microgram/mL for IL-2 and approximately 0.28 microgram/mL for IL-4). By Western blot, IL-4 was found to be secreted as two small polypeptides with molecular masses of approximately 18-20 kDa. The biological activity of IL-2 was determined by cell proliferation of the IL-2-dependent murine CTLL-2 cell line, while that of IL-4 was determined by cell proliferation of the CTLL-2 cell line [CT.h4S] which was stably transfected with the human IL-4 receptor. These findings indicate that plant suspension culture can be used to produce and secrete into the medium a variety of biologically active mammalian proteins that are of clinical and diagnostic relevance.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9631514     DOI: 10.1006/prep.1998.0872

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  17 in total

Review 1.  Plants as bioreactors for protein production: avoiding the problem of transgene silencing.

Authors:  C De Wilde; H Van Houdt; S De Buck; G Angenon; G De Jaeger; A Depicker
Journal:  Plant Mol Biol       Date:  2000-06       Impact factor: 4.076

Review 2.  'Molecular farming' of antibodies in plants.

Authors:  Stefan Schillberg; Rainer Fischer; Neil Emans
Journal:  Naturwissenschaften       Date:  2003-02-18

3.  Enhanced production of recombinant proteins from plant cells by the application of osmotic stress and protein stabilization.

Authors:  Ryan G Soderquist; James M Lee
Journal:  Plant Cell Rep       Date:  2005-02-08       Impact factor: 4.570

4.  Development of Cucumber mosaic virus as a vector modifiable for different host species to produce therapeutic proteins.

Authors:  Kouki Matsuo; Jin-Sung Hong; Noriko Tabayashi; Akira Ito; Chikara Masuta; Takeshi Matsumura
Journal:  Planta       Date:  2006-07-05       Impact factor: 4.116

5.  Production of human serum albumin by sugar starvation induced promoter and rice cell culture.

Authors:  Li-Fen Huang; Yu-Kuo Liu; Chung-An Lu; Shie-Liang Hsieh; Su-May Yu
Journal:  Transgenic Res       Date:  2005-10       Impact factor: 2.788

6.  Expression of bioactive human interferon-gamma in transgenic rice cell suspension cultures.

Authors:  Tzy-Li Chen; Yi-Ling Lin; Yi-Ling Lee; Ning-Sun Yang; Ming-Tsair Chan
Journal:  Transgenic Res       Date:  2004-10       Impact factor: 2.788

7.  Elastin-like polypeptide fusions enhance the accumulation of recombinant proteins in tobacco leaves.

Authors:  Jignasha Patel; Hong Zhu; Rima Menassa; Laszlo Gyenis; Alex Richman; Jim Brandle
Journal:  Transgenic Res       Date:  2006-11-15       Impact factor: 2.788

8.  Expression of the bovine growth hormone alters the root morphology in transgenic tobacco plants.

Authors:  Kyunghee Oh; Ban Yoon Cheon; Sung Hyun Cho; Hoang Quoc Truong; Sung Han Ok; Ji Ung Jeung; Jang Won Choi; Jeong Sheop Shin
Journal:  Transgenic Res       Date:  2003-06       Impact factor: 2.788

9.  Expression of anti human IL-4 and IL-6 scFvs in transgenic tobacco plants.

Authors:  P Ehsani; A Meunier; F Nato; A Jafari; A Nato; P Lafaye
Journal:  Plant Mol Biol       Date:  2003-05       Impact factor: 4.076

10.  Production of functional native human interleukin-2 in tobacco chloroplasts.

Authors:  Xing-Hai Zhang; Patricia Keating; Xia-Wei Wang; Yi-Hong Huang; James Martin; James X Hartmann; Aimin Liu
Journal:  Mol Biotechnol       Date:  2014-04       Impact factor: 2.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.